AYAGENE is a preclinical biopharmaceutical platform company focused on solving an unmet need by the further expedited drug development and commercialization of its “first-in-class” small molecule library which has been discovered and is currently being tested for treatment by a leading Academic University and contract research services provider that specialize in drug discovery.
| Website | http://www.ayagene.com |
| Employees | 4 (4 on RocketReach) |
| Founded | 2013 |
| Address | 3422 Old Capital Trail Suite 700, Wilmington, Delaware 19808, US |
| Technologies | |
| Industry | Biotechnology Research |
| Keywords | Molecular Medicine, Biopharmaceutical, First-In-Class, Drug Development, Small Molecule, Preclinical, Platform, Therapeutics, Pharmaceutical Research, Drug Discovery, Biotechnology, Life Sciences, Clinical Trials, Medicinal Chemistry, Pharmaceutical, Biotechnology Research, Drug Commercialization, Innovative Medicines, Health Technology |
Looking for a particular AYAGENE employee's phone or email?
AYAGENE Questions
Chris Mahne is the CEO of AYAGENE.
4 people are employed at AYAGENE.
AYAGENE is based in Wilmington, Delaware.
Top AYAGENE Employees
-
Chris Mahne
CEO at AYAGENE
San José, CR14 -
Tyson Yono
Direct of Special Project at AYAGENE
Bloomfield Hills, MI, US12 -
Saifullahi Sarafadin
Fashion Designer at AYAGENE
Ibadan, YO, NG -
Saifullahi Ibrahim
Fashion Designer at AYAGENE
Lagos, LA, NG
Related Companies
G2Crowd Trusted
300K+
Plugin Users
